Can aggressive multiple myeloma go into and stay in remission

Can Aggressive Multiple Myeloma Go Into Remission?

Yes, aggressive multiple myeloma can achieve remission, even with high-risk features.

What the Evidence Shows:

Modern treatment approaches—particularly combinations of proteasome inhibitors, immunomodulatory drugs (IMiDs), and monoclonal antibodies—have improved remission rates significantly, even for aggressive disease.

According to NCCN Guidelines for Multiple Myeloma, patients with high-risk disease are typically treated with intensive multi-drug regimens designed to achieve deep remission (minimal residual disease-negative status when possible).

Remission Duration:

• Some patients with aggressive myeloma achieve durable remissions lasting years
• Others may have shorter remission periods before relapse
• Maintenance therapy after initial treatment helps extend remission length
• Individual outcomes vary based on specific genetic features and treatment response

Key Variables:

The likelihood and duration of remission depend on:

• Specific high-risk cytogenetic features present
• Treatment regimen used
• How well the disease responds initially
• Whether minimal residual disease (MRD) is achieved

---

Questions for your oncology team:

1. What is the expected remission duration for my specific risk profile?
2. What maintenance therapy do you recommend?
3. How will you monitor for early relapse?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.